236 related articles for article (PubMed ID: 31582562)
1. The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity.
Nguyen TV; Yao S; Wang Y; Rolfe A; Selvaraj A; Darman R; Ke J; Warmuth M; Smith PG; Larsen NA; Yu L; Zhu P; Fekkes P; Vaillancourt FH; Bolduc DM
J Biol Chem; 2019 Nov; 294(45):16966-16977. PubMed ID: 31582562
[TBL] [Abstract][Full Text] [Related]
2. The DNMT3A R882H mutation does not cause dominant negative effects in purified mixed DNMT3A/R882H complexes.
Emperle M; Dukatz M; Kunert S; Holzer K; Rajavelu A; Jurkowska RZ; Jeltsch A
Sci Rep; 2018 Sep; 8(1):13242. PubMed ID: 30185810
[TBL] [Abstract][Full Text] [Related]
3. The R882H substitution in the human
Sandoval JE; Reich NO
J Biol Chem; 2019 Nov; 294(48):18207-18219. PubMed ID: 31640986
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for impairment of DNA methylation by the DNMT3A R882H mutation.
Anteneh H; Fang J; Song J
Nat Commun; 2020 May; 11(1):2294. PubMed ID: 32385248
[TBL] [Abstract][Full Text] [Related]
5. The DNMT3A R882H mutant displays altered flanking sequence preferences.
Emperle M; Rajavelu A; Kunert S; Arimondo PB; Reinhardt R; Jurkowska RZ; Jeltsch A
Nucleic Acids Res; 2018 Apr; 46(6):3130-3139. PubMed ID: 29518238
[TBL] [Abstract][Full Text] [Related]
6. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.
Russler-Germain DA; Spencer DH; Young MA; Lamprecht TL; Miller CA; Fulton R; Meyer MR; Erdmann-Gilmore P; Townsend RR; Wilson RK; Ley TJ
Cancer Cell; 2014 Apr; 25(4):442-54. PubMed ID: 24656771
[TBL] [Abstract][Full Text] [Related]
7. Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns.
Emperle M; Adam S; Kunert S; Dukatz M; Baude A; Plass C; Rathert P; Bashtrykov P; Jeltsch A
Nucleic Acids Res; 2019 Dec; 47(21):11355-11367. PubMed ID: 31620784
[TBL] [Abstract][Full Text] [Related]
8. Functional Analysis of DNMT3A DNA Methyltransferase Mutations Reported in Patients with Acute Myeloid Leukemia.
Khrabrova DA; Loiko AG; Tolkacheva AA; Cherepanova NA; Zvereva MI; Kirsanova OV; Gromova ES
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31861499
[TBL] [Abstract][Full Text] [Related]
9. Oligomerization and binding of the Dnmt3a DNA methyltransferase to parallel DNA molecules: heterochromatic localization and role of Dnmt3L.
Jurkowska RZ; Rajavelu A; Anspach N; Urbanke C; Jankevicius G; Ragozin S; Nellen W; Jeltsch A
J Biol Chem; 2011 Jul; 286(27):24200-7. PubMed ID: 21566127
[TBL] [Abstract][Full Text] [Related]
10. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
[TBL] [Abstract][Full Text] [Related]
11. DNMT3A R882H mutation promotes acute leukemic cell survival by regulating glycolysis through the NRF2/NQO1 axis.
Chu X; Zhong L; Dan W; Wang X; Zhang Z; Liu Z; Lu Y; Shao X; Zhou Z; Chen S; Liu B
Cell Signal; 2023 May; 105():110626. PubMed ID: 36758683
[TBL] [Abstract][Full Text] [Related]
12. Preferential Self-interaction of DNA Methyltransferase DNMT3A Subunits Containing the R882H Cancer Mutation Leads to Dominant Changes of Flanking Sequence Preferences.
Mack A; Emperle M; Schnee P; Adam S; Pleiss J; Bashtrykov P; Jeltsch A
J Mol Biol; 2022 Apr; 434(7):167482. PubMed ID: 35131259
[TBL] [Abstract][Full Text] [Related]
13. Dnmt3b Methylates DNA by a Noncooperative Mechanism, and Its Activity Is Unaffected by Manipulations at the Predicted Dimer Interface.
Norvil AB; Petell CJ; Alabdi L; Wu L; Rossie S; Gowher H
Biochemistry; 2018 Jul; 57(29):4312-4324. PubMed ID: 27768276
[TBL] [Abstract][Full Text] [Related]
14. DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway.
Chu X; Zhong L; Dan W; Wang X; Zhang Z; Liu Z; Lu Y; Shao X; Zhou Z; Chen S; Liu B
Cell Commun Signal; 2022 Oct; 20(1):168. PubMed ID: 36303144
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for DNMT3A-mediated de novo DNA methylation.
Zhang ZM; Lu R; Wang P; Yu Y; Chen D; Gao L; Liu S; Ji D; Rothbart SB; Wang Y; Wang GG; Song J
Nature; 2018 Feb; 554(7692):387-391. PubMed ID: 29414941
[TBL] [Abstract][Full Text] [Related]
16. Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs.
Yang L; Liu Y; Zhang N; Ding X; Zhang W; Shen K; Huang L; Zhou J; Cui S; Zhu Z; Hu Z; Xiao M
Oncotarget; 2017 May; 8(18):30395-30409. PubMed ID: 28418922
[TBL] [Abstract][Full Text] [Related]
17. AML-Associated Mutations in DNA Methyltransferase DNMT3A.
Khrabrova DA; Yakubovskaya MG; Gromova ES
Biochemistry (Mosc); 2021 Mar; 86(3):307-318. PubMed ID: 33838631
[TBL] [Abstract][Full Text] [Related]
18. Effect of
Tabatabaei T; Rezvany MR; Ghasemi B; Vafaei F; Zadeh MK; Zaker F; Salmaninejad A
Biomed Res Int; 2024; 2024():9625043. PubMed ID: 38807916
[TBL] [Abstract][Full Text] [Related]
19. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
Sandoval JE; Huang YH; Muise A; Goodell MA; Reich NO
J Biol Chem; 2019 Mar; 294(13):4898-4910. PubMed ID: 30705090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]